As shown in Fig. 1e, the TOP2A vaccination significantly reduced tumor volume as compared to the adjuvant control (CpG only) with an average tumor size of 736 mm3 in adjuvant controls vs. 11 mm3 in vaccinated mice (p < 0.05). Here, TOP2A is linked to neoplasm.